Latest News & Features
Americas
Amgen has accused India-based Emcure Pharmaceuticals of patent infringement, in a bid to protect its drug Sensipar. 10 September 2018
Americas
Seven states have urged the US Court of Appeals for the Federal Circuit to rehear a decision rejecting the use of tribal sovereign immunity in the inter partes review process. 10 September 2018
Biotechnology
Biotech company Shire yesterday revealed plans to acquire a Switzerland-based plasma collection company. 7 September 2018
Americas
The misuse of federal drug programmes by branded pharmaceutical companies is costing the US healthcare system $13.4 billion per year in lost savings, a report commissioned by a generics trade group has claimed. 6 September 2018
Americas
Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million. 6 September 2018
Americas
US-based Gilead announced Tuesday, September 4 that it has entered into a licensing agreement with biotech company Trianni for an undisclosed sum. 6 September 2018
Americas
A well-functioning linkage system for patents and drugs allows healthcare and patent authorities to maximise the impact of innovation, say Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril, who report on the Mexican landscape. 6 September 2018
Big Pharma
International law firm Simmons & Simmons has hired a new IP team to boost its office in Milan. 5 September 2018
Americas
Stephen Knight was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 5 September 2018
Americas
Mexico has international depositary authority (IDA) status under the Budapest Treaty, which speeds up the patent process for microorganisms. Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reviews the impact of the IDA on biotech patents in the country. 5 September 2018